Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors

Radiation Oncology

Volumn 2, Issue 1, 2007, Pages

  Yamashita, Hideomi ^a   Nakagawa, Keiichi ^a   Nakamura, Naoki ^a   Koyanagi, Hiroki ^a   Tago, Masao ^a   Igaki, Hiroshi ^a   Shiraishi, Kenshiro ^a   Sasano, Nakashi ^a   Ohtomo, Kuni ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INCIDENCE; LUNG TUMOR; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; RADIATION PNEUMONIA; RADIATION RESPONSE; RADIOSURGERY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PARTICLE ACCELERATORS; RADIATION PNEUMONITIS; RADIOSURGERY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34347390438     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-2-21     Document Type: Article

References (40)

1. Nagata Y Negoro Y Aoki T Mizowaki T Takayama K Kokubo M Araki N Mitsumori M Sasai K Shibamoto Y Koga S Yano S Hiraoka M Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame Int J Radiat Oncol Biol Phys 2002 52 1041-1046 10.1016/S0360-3016(01)02731-6 11958900
2. Uematsu M Shioda A Tahara K Fukui T Yamamoto F Tsumatori G Ozeki Y Aoki T Watanabe M Kusano S Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients a preliminary experience Cancer 1998 82 1062-1070 10.1002/ (SICI)1097-0142(19980315)82:6<1062::AID-CNCR8>3.0.CO;2-G 9506350
3. Nakagawa K Aoki Y Tago M Terahara A Ohtomo K Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors original research in the treatment of thoracic neoplasms Int J Radiat Oncol Biol Phys 2000 48 449-457 10.1016/S0360-3016(00)00617-9 10974461
4. Wulf J Hadinger U Oppitz U Thiele W Ness-Dourdoumas R Flentje M Stereotactic radiotherapy of targets in the lung and liver Strahlenther Onkol 2001 177 645-655 10.1007/PL00002379 11789403
5. Hara R Itami J Kondo T Aruga T Abe Y Ito M Fuse M Shinohara D Nagaoka T Kobiki T Stereotactic single high dose irradiation of lung tumors under respiratory gating Radiother Oncol 2002 63 159-163 10.1016/ S0167-8140(02)00063-4 12063005
6. Onimaru R Shirato H Shimizu S Kitamura K Xu B Fukumoto S Chang TC Fujita K Oita M Miyasaka K Nishimura M Dosaka-Akita H Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers Int J Radiat Oncol Biol Phys 2003 56 126 135 10.1016/S0360-3016(03)00095-6 12694831
7. Hof H Herfarth KK Munter M Hoess A Motsch J Wannenmacher M Debus JJ Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 2003 56 335-341 10.1016/ S0360-3016(02)04504-2 12738306
8. Whyte RI Crownover R Murphy MJ Martin DP Rice TW DeCamp MM Jr Rodebaugh R Weinhous MS Le QT Stereotactic radiosurgery for lung tumors preliminary report of a phase I trial Ann Thorac Surg 2003 75 1097 1101 10.1016/S0003-4975(02)04681-7 12683544
9. Takai Y Mituya M Nemoto K Ogawa Y Kakuto Y Matusita H Takeda K Takahashi C Yamada S [Simple method of stereotactic radiotherapy without stereotactic body frame for extracranial tumors] Nippon Igaku Hoshasen Gakkai Zasshi 2001 61 403-407 11524815
10. Timmerman R McGarry R Yiannoutsos C Papiez L Tudor K DeLuca J Ewing M Abdulrahman R DesRosiers C Williams M Fletcher J Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 2006 24 4833-4839 10.1200/JCO.2006.07.5937 17050868
11. Graham MV Purdy JA Emami B Harms W Bosch W Lockett MA Perez CA Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 1999 45 323-329 10.1016/S0360-3016(99)00183-2 10487552
12. Matsuo Y Takayama K Nagata Y Kunieda E Tateoka K Ishizuka N Mizowaki T Norihisa Y Sakamoto M Narita Y Ishikura S Hiraoka M Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer Int J Radiat Oncol Biol Phys 2007 68 416-425 17363190
13. Lagerwaard FJ Van Sornsen de Koste JR Nijssen-Visser MR Schuchhard-Schipper RH Oei SS Munne A Senan S Multiple "slow" CT scans for incorporating lung tumor mobility in radiotherapy planning Int J Radiat Oncol Biol Phys 2001 51 932-937 10.1016/ S0360-3016(01)01716-3 11704313
14. van Sornsen de Koste JR Lagerwaard FJ Schuchhard-Schipper RH Nijssen-Visser MR Voet PW Oei SS Senan S Dosimetric consequences of tumor mobility in radiotherapy of stage I non-small cell lung cancer--an analysis of data generated using 'slow' CT scans Radiother Oncol 2001 61 93-99 10.1016/S0167-8140(01)00373-5 11578735
15. Therasse P Arbuck SG Eisenhauer EA Wanders J Kaplan RS Rubinstein L Verweij J Van Glabbeke M van Oosterom AT Christian MC Gwyther SG New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 2000 92 205-216 10.1093/jnci/92.3.205 10655437
16. Knoos T Kristensen I Nilsson P Volumetric and dosimetric evaluation of radiation treatment plans: Radiation conformity index Int J Radiat Oncol Biol Phys 1998 42 1169-1176 10.1016/S0360-3016(98)00239-9 9869245
17. Hara R Itami J Komiyama T Katoh D Kondo T Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors Chest 2004 125 340-344 10.1378/ chest.125.1.340 14718465
18. Takayama K Nagata Y Negoro Y Mizowaki T Sakamoto T Sakamoto M Aoki T Yano S Koga S Hiraoka M Treatment planning of stereotactic radiotherapy for solitary lung tumor Int J Radiat Oncol Biol Phys 2005 61 1565-1571 10.1016/j.ijrobp.2004.12.066 15817363
19. Song DY Benedict SH Cardinale RM Chung TD Chang MG Schmidt-Ullrich RK Stereotactic body radiation therapy of lung tumors: Preliminary experience using normal tissue complication probability-based dose limits Am J Clin Oncol 2005 28 591-596 10.1097/ 01.coc.0000182428.56184.af 16317270
20. Onishi H Nagata Y Shirato H Gomi K Karasawa K Arimoto T Hayakawa K Takai Y Kimura T Takeda A Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma: Clinical outcomes in 273 cases of a Japanese multi-institutional study ASCO 2004 22 14S (July 15 Supplement) abstract No: 7003
21. Wulf J Haedinger U Oppitz U Thiele W Mueller G Flentje M Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients Int J Radiat Oncol Biol Phys 2004 60 186-196 10.1016/j.ijrobp.2004.02.060 15337555
22. Anonymous Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50) Report 62, International Commission on Radiation Units and Measurements Washington, DC 1999
23. Shaw E Kline R Gillin M Souhami L Hirschfeld A Dinapoli R Martin L Radiation Therapy Oncology Group: Radiosurgery quality assurance guidelines Int J Radiat Oncol Biol Phys 1993 27 1231-1239 8262852
24. Feuvret L Noel G Mazeron JJ Bey P Conformity index: A review Int J Radiat Oncol Biol Phys 2006 64 333-342 10.1016/j.ijrobp.2005.09.028 16414369
25. Paddick I A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note J Neurosurg 2000 93 Suppl 3 219-222 11143252
26. Takayama K Nagata Y Negoro Y Mizowaki T Sakamoto T Sakamoto M Aoki T Yano S Koga S Hiraoka M Treatment planning of stereotactic radiotherapy for solitary lung tumor Int J Radiat Oncol Biol Phys 2005 61 1565-1571 10.1016/j.ijrobp.2004.12.066 15817363
27. Armstrong J McGibney C The impact of three-dimensional radiation on the treatment of non-small cell lung cancer Radiother Oncol 2000 56 157-167 10.1016/S0167-8140(00)00207-3 10927134
28. Dearnaley DP Khoo VS Norman AR Meyer L Nahum A Tait D Yarnold J Horwich A Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial Lancet 1999 353 267-272 10.1016/S0140-6736(98)05180-0 9929018
29. Lee WR Hanks GE Hanlon AL Schultheiss TE Hunt MA Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect Int J Radiat Oncol Biol Phys 1996 35 251-257 10.1016/0360-3016(96)00064-8 8635930
30. Yorke ED Jackson A Rosenzweig KE Merrick SA Gabrys D Venkatraman ES Burman CM Leibel SA Ling CC Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small cell lung cancer patients treated with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 2002 54 329-339 10.1016/S0360-3016(02)02929-2 12243805
31. Hernando ML Marks LB Bentel GC Zhou SM Hollis D Das SK Fan M Munley MT Shafman TD Anscher MS Lind PA Radiation induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer Int J Radiat Oncol Biol Phys 2001 51 650-659 10.1016/S0360-3016(01)01685-6 11597805
32. Paludan M Traberg Hansen A Petersen J Grau C Hoyer M Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency? Acta Oncol 2006 45 818-822 10.1080/02841860600915314 16982545
33. Kohno N Hamada H Fujioka S Hiwada K Yamakido M Akiyama M Circulating Antigen KL-6 and Lactate Dehydorogenase for Monitoring Irradiated Patients with Lung Cancer Chest 1992 102 117-122 1320562
34. Kohno N Kyoizumi S Awaya Y Fukuhara H Yamakido M Akiyama M New serum indicator of interstitial pneumonitis activity: Sialylated carbohydrate antigen KL-6 Chest 1989 96 68-73 2661160
35. Goto K Kodama T Sekine I Kakinuma R Kubota K Hojo F Matsumoto T Ohmatsu H Ikeda H Ando M Nishiwaki Y Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis Lung Cancer 2001 34 141-148 10.1016/ S0169-5002(01)00215-X 11557124
36. Kohno N Kyoizumi S Awaya Y Fukuhara H Yamakido M Akiyama M New serum indicator of interstitial pneumonitis activity: Sialylated carbohydrate antigen KL-6 Chest 1989 96 68-73 2661160
37. Wara WM Phillips TL Margolis LW Smith V Radiation pneumonitis: A new approach to the derivation of time-dose factors Cancer 1973 32 547-552 10.1002/1097-0142(197309)32:3<547::AID-CNCR2820320306>3.0.CO;2-4 4726962
38. Fritz P Kraus HJ Muhlnickel W Hammer U Dolken W Engel-Riedel W Chemaissani A Stoelben E Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases Radiat Oncol 2006 1 30 1579222 16919172 10.1186/1748-717X-1-30
39. Belderbos JS De Jaeger K Heemsbergen WD Seppenwoolde Y Baas P Boersma LJ Lebesque JV First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy Radiother Oncol 2003 66 119-126 10.1016/ S0167-8140(02)00377-8 12648783
40. Hope AJ Lindsay PE El Naqa I Alaly JR Vicic M Bradley JD Deasy JO Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters Int J Radiat Oncol Biol Phys 2006 65 112-124 10.1016/ j.ijrobp.2005.11.046 16618575